Abbott Labs's most recent trend suggests a bullish bias. One trading opportunity on Abbott Labs is a Bull Put Spread using a strike $105.00 short put and a strike $97.50 long put offers a potential 15.92% return on risk over the next 36 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $105.00 by expiration. The full premium credit of $1.03 would be kept by the premium seller. The risk of $6.47 would be incurred if the stock dropped below the $97.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Abbott Labs is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Abbott Labs is bullish.
The RSI indicator is at 61.8 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Abbott Labs
Why These 3 Coronavirus-Related Stocks Plummeted More Than 35% in August
Tue, 08 Sep 2020 19:58:00 +0000
Shares of COVID-19 vaccine developer Vaxart (NASDAQ: VXRT) and coronavirus diagnostic test manufacturers Opko Health (NASDAQ: OPK) and Quidel (NASDAQ: QDEL) plunged more than 35% in August, according to data provided by S&P Global Market Intelligence. Vaxart's shares were down 36.9%, Opko's fell 37.1%, and Quidel's dropped 37.7% for the month. Opko's and Quidel's shares are up more than 100% so far in 2020, while Vaxart's have risen a jaw-dropping 1,300%.
REFILE-From Target to Twitter, U.S. companies urge workers to vote
Mon, 07 Sep 2020 15:39:38 +0000
From Georgia to Wisconsin to Ohio earlier this year, voters in primary elections were stuck for hours in lines from sharply reduced polling locations. Heeding the stark warning ahead of Election Day on Nov. 3, U.S. companies are aiming to facilitate what is expected to be a chaotic 2020 U.S. presidential election. Twitter and Apple are giving workers paid time off to get to ballot boxes.
Abbott Begins BTK Clinical Trial to Evaluate DRS Therapy
Mon, 07 Sep 2020 12:53:12 +0000
Abbott (ABT) aims to provide a new treatment option for patients with CLI BTK, thus eliminating the need for any additional treatment.
Is Abbott Laboratories Stock a Buy?
Sun, 06 Sep 2020 12:30:00 +0000
This coronavirus stock is pretty pricey, but it could see even more gains as COVID-19 testing increases.
3 Top Coronavirus Stocks to Buy in September
Sun, 06 Sep 2020 11:10:00 +0000
It seems we're nearing the finale of the coronavirus vaccine race. Eight programs have reached late-stage clinical testing, and the U.S. has vowed to help usher a possible vaccine to market by January. In recent months, clinical-stage biotech companies have stolen the spotlight in the coronavirus fight.
Related Posts
Also on Market Tamer…
Follow Us on Facebook